Viewing StudyNCT00625664



Ignite Creation Date: 2024-05-05 @ 7:13 PM
Last Modification Date: 2024-10-26 @ 9:45 AM
Study NCT ID: NCT00625664
Status: COMPLETED
Last Update Posted: 2016-05-05
First Post: 2008-02-19

Brief Title: Larotaxel Cisplatin Versus Gemcitabine Cisplatin in First Line Treatment of Locally AdvancedMetastatic Urothelial Tract or Bladder Cancer
Sponsor:
Organization: Sanofi